Susan F. Slovin

Also affiliated with Kettering University, Sidney Kimmel Center for Prostate and Urologic Cancers

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Papers

Driven by 13 papers — median percentile 0. Top paper: “Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study”.

Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0855

N/A

2.2DataRank · unranked

68 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

A Phase I Trial of IGF-1R Inhibitor Cixutumumab and mTOR Inhibitor Temsirolimus in Metastatic Castration-resistant Prostate Cancer

Clinical Genitourinary Cancer(2020)10.1016/j.clgc.2019.10.013

N/A

0DataRank · unranked

33 citations

Jay Chudow, Mia DeNunzio, Susan F. Slovin, Daniel C. Danila, Michael J. Morris +3 more

Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy

European Urology Open Science(2021)10.1016/j.euros.2021.09.015

N/A

0DataRank · unranked

19 citations

Emmanuel S. Antonarakis, Tina Mayer, Daniel H. Shevrin, Mark N. Stein, Ulka N. Vaishampayan +22 more

TROP-2 co-expression with androgen receptor splice variants as a new therapeutic target in prostate cancer.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5060

N/A

0DataRank · unranked

2 citations

Jamie M. Sperger, Susan F. Slovin, Scott T. Tagawa, Christos E. Kyriakopoulos, Manish Kohli +5 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more

Clinical annotations for prostate cancer research: Defining data elements, creating a reproducible analytical pipeline, and assessing data quality.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.064

Top 100%

0DataRank

Top 100%0 citations

Samantha E. Vasselman, Ethan Barnett, Barbara Nweji, Emily Carbone, Alexander Blum +10 more

Expression and Therapeutic Targeting of TROP-2 in Treatment-Resistant Prostate Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1305

N/A

0DataRank · unranked

54 citations

Kyle T. Helzer, Charlotte N. Stahlfeld, Dawei Jiang, Anupama Singh, Katherine R. Kaufmann +19 more

Evaluating Immune-Related Adverse Events Using PRO-CTCAE in a Phase II Study of Ipilimumab for Hormone-Sensitive Prostate Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-23-9

N/A

0DataRank · unranked

5 citations

Justine Anderson, Daniel C. Danila, Michael J. Morris, Susan F. Slovin, Wassim Abida +5 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Data from Immunomodulatory Activity of a Colony-stimulating Factor-1 Receptor Inhibitor in Patients with Advanced Refractory Breast or Prostate Cancer: A Phase I Study

(2023)10.1158/1078-0432.c.6529578.v1

N/A

0DataRank · unranked

0 citations

Christopher A. Klebanoff, David Schaer, John Kauh, Susan F. Slovin, Matthew Adamow +25 more

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3403

N/A

0DataRank · unranked

54 citations

Vignesh Ravichandran, Samantha Brown, Syed M. Alam, Andrew Katims, Hong Truong +25 more

Clinical, Imaging, and Technical Factors Associated with Successful Genomic Profiling of Bone Biopsy Tissue in Prostate Cancer

European Urology Oncology(2024)10.1016/j.euo.2024.07.007

N/A

0DataRank · unranked

5 citations

Hebert Alberto Vargas, Daniel J. Holzwanger, Heiko Schöder, Emily Waters, Elena N. Petre +13 more

Infections in Patients with Solid Tumors Undergoing Adoptive Cellular Therapy

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.02.017

N/A

0DataRank · unranked

2 citations

Jumanah N Algazaq, Kenneth Seier, Rhoena Desir-Camille, Li-Xuan Qin, Olayode Babatunde +12 more

Susan F. Slovin

Indexed papers

Top data-sharing exemplar

Papers